Dr. Leslie Cunningham is the Clinical Director of the Center for Chronic Medical Conditions (CCMC) and Co-Director of the Pediatric Assessment Center (PAC) at CFI-Westchester and Manhattan. Dr. Cunningham received her B.A. in Psychology and a Ph.D. in Clinical & School Psychology from the University of Virginia and her pre-doctoral internship at the Virginia Treatment Center for Children at the MCV/VCU Health System. She completed a two-year post-doctoral fellowship at the Dana-Farber Cancer Institute and Children’s Hospital Boston, where she worked with the pediatric brain tumor population providing individual, group, and family therapy, behavioral interventions around medical procedures, and anticipatory grief and bereavement support. Dr. Cunningham was then appointed as faculty at Harvard Medical School, working as a staff psychologist at Dana-Farber as part of the School Liaison Program, where she worked to ensure that patients who have completed treatment for childhood cancer were receiving the most appropriate school-based accommodations and services. During this time, Dr. Cunningham also maintained a private practice conducting neuropsychological evaluations with children and adults. Dr. Cunningham was on the faculty at the Albert Einstein College of Medicine for several years, where she worked as the psychologist within the Division of Pediatric Hematology, Oncology, and Blood and Bone Marrow Transplantation at Children’s Hospital at Montefiore. Her clinical work focused on the adjustment of children and adults to achronic or life-threatening illness, adherence to medical treatment, cognitive-behavioral interventions to address chronic pain, and anticipatory grief and bereavement. She also conducted neuropsychological evaluations with patients who were at risk for learning and processing deficits secondary to the neurotoxicity from cancer-directed treatment or prolonged severe anemia. Dr. Cunningham works closely with children's’ schools to ensure that each child receives specific classroom interventions and accommodations needed due to physical and/or neurocognitive sequelae from disease or disease-related treatment.